BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Ash Access Technology, Inc. 

INOK Business Center
3601 Sagamore Parkway North
Lafayette  Indiana  47904  U.S.A.
Phone: n/a Fax: 765-742-4823


SEARCH JOBS


Industry
Medical Device






 Company News
Ash Access Technology, Inc. and Commercial Partner AngioDynamics (ANGO) Highlight Results From Preliminary Study of Centros(TM) 1/25/2008 9:24:50 AM    More...
Ash Access Technology, Inc. Completes Patient Enrollment in AZEPTIC Trial for Zuragen(R) 1/25/2008 9:21:44 AM    More...
Ash Access Technology, Inc. Appoints Dr. Al Guillem As Vice President, Scientific And Quality Affairs 1/12/2007 10:46:21 AM    More...
Ash Access Technology, Inc. Investigational Antimicrobial / Antithrombotic Therapy (Zuragen(TM)) Pivotal Clinical Trial Begins 10/3/2006 10:30:33 AM    More...
Ash Access Technology, Inc. Partners With DaVita Clinical Research To Conduct Pivotal FDA Clinical Trial 2/16/2006 12:58:33 PM    More...
Ash Access Technology, Inc. Announces a Private Fund Managed By Bear Stearns And Other New Investors Have Subscribed To Their $6M Series B Round Of Financing 1/24/2006 1:28:35 PM    More...
FDA Notifies Ash Access Technology, Inc. Of Approved IDE For Final Formulation Of "MethLock(TM)," A New Antimicrobial, Anti-Biofilm Catheter Lock Expected To Outperform Heparin 10/19/2005 5:13:05 PM    More...
FDA Approves Clinical Trial For Ash Access Technology, Inc.'s MethLock(TM) Solution 10/19/2005 5:09:59 PM    More...
Ash Access Technology, Inc. Awarded a $2.7M SBIR Fast-Track Grant From National Institutes of Health (NIH) NIDDK To Fund The Imminent Clinical Trial Of The Company's Catheter Lock Solution, "MethLock(TM)," With Its Antimicrobial And Anti-Biofilm Properties 10/19/2005 5:09:20 PM    More...

//-->